Bora Pharmaceuticals acquires Eden Biologics CDMO Assets - PRN India News webindia123.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webindia123.com Daily Mail and Mail on Sunday newspapers.
Fast-growing contract development and manufacturing organization (CDMO) BORA Pharmaceuticals, has announced a planned investment of $10 million to expand its Oral Solid Dose capabilities across facilities in Zhunan, Taiwan and Mississauga, Ontario.The company’s CEO, Bobby Sheng, said the expansion, which will.
Taiwan based contract manufacturer, Bora Pharmaceuticals, in partnership with Taishin Healthcare Limited, is ready to spend millions to expand its footprint in the CDMO sector.
05.11.21 FDA Issues Pandemic Remote Inspection Guidance For Drug Manufacturing Facilities
Sponsor
In this free live webinar, we will provide an overview of the strategy to speed up the migration from a vial to a pre-fillable syringe when developing a vaccine. We will discuss the different packaging characteristics, assess the syringe platform, and present what Stevanato Group can offer to support pharma partners in delivering a safe and effective vaccine.
Featured Editorial
On April 14, 2021, the FDA released a new guidance,
Remote Interactive Evaluations of Drug Manufacturing and Bioresearch Monitoring Facilities During the COVID-19 Public Health Emergency. This article discusses planning, conducting, and concluding a remote interactive evaluation under this guidance and shares how to submit public comments for FDA consideration.